I have done majority of the writing. I need the last few section highlighted in red to be changed according to the new references. also would appreciate proof reading and finalisisng the document with references in harvard style.
References
Brown, J., Smith, A., & Johnson, R.,
2022. Optimizing Monitoring Practices for DOACs in the UK: A Quantitative
Survey. Journal of Thrombosis and Haemostasis, 20(4), pp. 345-352.
Clark, D., Wright, A., & Harris, T.,
2022. Barriers to Optimal Prescribing Practices for DOACs: A Qualitative
Analysis. BMJ Open, 12(8), pp. e058345.
Edwards, H., Wilson, S., & Clark, P.,
2021. Evaluating Patient and Provider Perspectives on DOAC Monitoring: A Mixed
Methods Approach. Journal of General Practice, 35(3), pp. 211-220.
Green, L., Harris, M., & White, D.,
2021. Patient Adherence to DOACs: A Mixed-Methods Study in the UK. British
Journal of Clinical Pharmacology, 87(6), pp. 679-688.
Harris, M., Walker, P., & Brown, J.,
2020. Perspectives of Healthcare Providers on DOAC Monitoring: A Qualitative
Study. International Journal of Cardiology, 300, pp. 123-130.
King, A., Parker, L., & Robinson, J.,
2022. Recent Advances in DOAC Monitoring and Prescribing Practices: A
Systematic Review. Pharmacy Practice Journal, 18(4), pp. 321-330.
Lewis, K., Parker, S., & Johnson, T.,
2023. Effectiveness of a New Monitoring Protocol for DOACs: A Randomized Trial
in the UK. Thrombosis Research, 214, pp. 100-108.
Martin, G., Roberts, L., & Davies, M.,
2023. Structured Monitoring of DOACs in Primary Care: Outcomes from a Cohort
Study. Primary Care Cardiovascular Journal, 15(1), pp. 45-52.
Walker, P., Green, L., & Brown, J.,
2022. Best Practices for DOAC Prescribing and Monitoring: A Systematic Review
of UK Studies. Journal of Clinical Pharmacy and Therapeutics, 47(2), pp.
245-255.
Wright, M., Green, S., & Lewis, J.,
2023. Prescribing Trends and Outcomes for DOACs in the UK: A Cross-Sectional
Study. British Medical Journal, 14(2), pp. 178-186.